In this frame, the studies reporting the vectorization of gold(I) and gold(III) complexes into HER2(+) tumoral cells for potential application in breast cancer therapy are based on the use of antibodies or peptides with high affinity and selectivity towards HER2 as vectors. The gene discussed is ERBB2; the disease is breast cancer.